John Milligan's most recent trade in 4D Molecular Therapeutics Inc was a trade of 33,750 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics Inc | John F. Milligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 33,750 | 33,750 | - | - | Stock Option (Right to Buy) | |
| Pacific Biosciences of | John F. Milligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 65,000 | 65,000 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of | John F. Milligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 32,179 | 32,179 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of | John F. Milligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 22,821 | 132,821 (0%) | 0% | 0 | Common Stock | |
| 4D Molecular Therapeutics Inc | John F. Milligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 26,791 | 26,791 | - | - | Stock Option (Right To Buy) | |
| 4D Molecular Therapeutics Inc | John F. Milligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 33,750 | 33,750 | - | - | Stock Option (Right to Buy) | |
| 4D Molecular Therapeutics Inc | John F. Milligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 33,750 | 33,750 | - | - | Stock Option (Right to Buy) | |
| Pacific Biosciences of | John F. Milligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 12,885 | 12,885 | - | - | Stock Option (right to buy) | |
| 4D Molecular Therapeutics Inc | John F. Milligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2021 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| 4D Molecular Therapeutics Inc | John F. Milligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2021 | 11,250 | 11,250 | - | - | Stock Option (Right to Buy) | |
| TherapeuticsMD Inc | John C.K. Milligan | Secretary/CEO of subsidiary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 103,500 | 1,796,955 (0%) | 0% | - | Common Stock | |
| TherapeuticsMD Inc | John C.K. Milligan | Secretary/CEO of subsidiary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 103,500 | 207,000 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | John C.K. Milligan | Secretary/CEO of subsidiary | Sale of securities on an exchange or to another person at price $ 1.04 per share. | 10 May 2021 | 44,252 | 1,752,703 (0%) | 0% | 1.0 | 46,022 | Common Stock |
| TherapeuticsMD Inc | John C.K. Milligan | President/Secretary | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Mar 2021 | 434,814 | 0 (0%) | 0% | 0 | Common Stock | |
| TherapeuticsMD Inc | John C.K. Milligan | President/Secretary | 04 Mar 2021 | 179,000 | 1,723,419 (0%) | 0% | 0.2 | 43,748 | Common Stock | |
| TherapeuticsMD Inc | John C.K. Milligan | President/Secretary | 04 Mar 2021 | 179,000 | 0 | - | - | Warrant (right to buy) | ||
| TherapeuticsMD Inc | John C.K. Milligan | President/Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.46 per share. | 04 Mar 2021 | 29,964 | 1,693,455 (0%) | 0% | 1.5 | 43,747 | Common Stock |
| 4D Molecular Therapeutics Inc | John F. Milligan | Director | Purchase of securities on an exchange or from another person at price $ 23.00 per share. | 15 Dec 2020 | 100,000 | 100,000 | - | 23 | 2,300,000 | Common Stock |
| TherapeuticsMD Inc | John C.K. Milligan | President/Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Nov 2020 | 360,000 | 360,000 | - | - | Restricted Stock Units | |
| Pacific Biosciences of | John F. Milligan | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2020 | 35,000 | 35,000 | - | - | Stock Option (right to buy) |